Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Sep;108(6):785-91.
doi: 10.1172/JCI14006.

CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism

M Febbraio  1 , D P Hajjar, R L Silverstein
Affiliations
Review

CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism

M Febbraio et al. J Clin Invest. 2001 Sep.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Antagonism of proangiogenic responses by CD36. In response to ligand engagement, a proangiogenic receptor (such as the VEGF or bFGF receptor) induces proliferation, migration, and tube formation of microvascular endothelial cells. In the presence of TSP-1, which interacts with a specific motif (CLESH) on its receptor, CD36, this response is inhibited. Inhibition is mediated through interaction with fyn, the activation of p38 MAP kinase, and, ultimately, caspase DNA cleavage, resulting in endothelial cell apoptosis.
Figure 2
Figure 2
CD36-mediated macrophage foam cell formation. In response to EC injury, macrophages and LDL transmigrate into the subendothelial space (I), where they may become entrapped. Inflammatory stimuli (II) lead to the secretion of oxidative products from ECs and macrophages, including nitric oxide (NO), hydrogen peroxide, and myeloperoxidase (MPO) (III), which act upon LDL particles and convert them into CD36-specific ligands, or ligands for other scavenger receptors (SR). Internalization of oxidized LDL via CD36 (IV) generates lipid byproducts (e.g., 9-HODE, 13-HODE, and PGJ2), mediated by lipoxygenase or other pathways, which in turn provide ligands for the transcription factor PPARγ (V). The binding of these lipids structurally enables PPARγ to dimerize with binding partners such as RXR and charges the complex for nuclear translocation and the activation of transcription of target genes (VI). Because these target genes include both PPARγ and CD36, a positive feedback loop arises. The increased expression of CD36 promotes further oxidized LDL uptake, perpetuating the cycle and resulting in accumulation of cholesterol ester by macrophages and eventually in foam cell formation (VII). Adapted from ref. .
See this image and copyright information in PMC

References

    1. Adams, J.C., Tucker, R.P., and Lawler, J. 1995. The thrombospondin gene family. R.G. Landes. Austin, Texas, USA.
    1. Silverstein RL, Febbraio M. CD36 and atherosclerosis. Curr Opin Lipidol. 2000;11:483–491. - PubMed
    1. Oquendo P, Hundt E, Lawler J, Seed B. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell. 1989;58:95–101. - PubMed
    1. Gruarin P, et al. CD36 is a ditopic glycoprotein with the N-terminal domain implicated in intracellular transport. Biochem Biophys Res Commun. 2000;275:446–454. - PubMed
    1. Asch AS, et al. Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain. Science. 1993;262:1436–1440. - PubMed

Publication types